WeVote
Log In

Bill

Bill

HB 1000

An Act amending the act of March 23, 1972 (P.L.136, No.52), known as the Professional Psychologists Practice Act, further providing for definitions, for State Board of Psychology and for powers of the board; providing for prescription certificate, for prescribing and administrative practices and for controlled substances; and further providing for refusal, suspension or revocation of license, for reporting of multiple licensure and for penalties and injunctions against unlawful practice.

2025-2026 Regular Session Introduced by Lisa Borowski and 10 co-sponsors

The bill prohibits most transition care for minors, imposes strict liability for harms from such care, broad civil remedies for detransitioners, and requires clinics to report trea

Referred to Professional Licensure
0
WeVote Research Nonpartisan
Bill Summary · HB 1000

Summary — HB 1000: "Detransitioners Bill of Rights"

Status: Passed 1st Reading (Introduced Jan 21, 2025)
Classification: Bill

Note: The packet includes multiple unrelated HB 1000 texts from other jurisdictions. This summary focuses on the version titled “Detransitioners Bill of Rights” (North Carolina, Session 2025) included in the materials.

Purpose / Intent

To (1) establish rights and legal remedies for individuals who have undergone gender transition and later seek to reverse or address harms from that treatment (“detransitioners”), and (2) regulate medical care and reporting related to gender transition and detransition — with particular provisions addressing minors, provider liability, and clinic reporting.

Key definitions

  • Detransitioner: a person who began or completed a gender transition procedure but later sought treatment to reverse effects or ceased treatment (hormones/puberty-blockers) for that reason.
  • Detransition procedure: treatments (medical, surgical, mental-health) intended to reverse effects of prior transition care or help cope with its effects.
  • Gender clinic: health care entity that provides or refers for surgical transition procedures or prescribes puberty blockers / cross-sex hormones.
  • The bill also includes explicit biological definitions of “male” and “female.”

Major provisions

  • Prohibitions for minors
    • It is unlawful for a medical professional to perform a surgical gender transition procedure on a minor or to prescribe/provide puberty-blocking drugs or cross-sex hormones to a minor.
    • Exception: notwithstanding that prohibition, a medical professional may — with informed parental/guardian consent — provide certain procedures including a “detransition procedure” to a minor (text lists permitted procedures; the bill contains an explicit exception mechanism).
  • Provider discipline and civil penalties
    • Violation by a medical professional is deemed unprofessional conduct; the bill directs license revocation (the draft text references at least a one‑year minimum suspension).
    • Entities that employ/contract with violating professionals may face civil penalties up to $250,000.
  • Civil remedies and damages
    • Strict liability: medical professionals (and their employing entities) who perform prohibited transition care on minors are strictly liable for physical, psychological, emotional, or physiological harms to the minor.
    • Detransitioners may bring civil actions (timing provisions in the draft: within 10 years from attaining age 18 or within 4 years from costs incurred — the bill contains some competing/edited timelines in committee drafts).
    • Remedies available: compensatory (including pain & suffering, lost income, loss of consortium), punitive damages, attorneys’ fees, court costs, and costs of subsequent detransition procedures.
    • Minors may sue through guardians before majority and personally after majority.
    • Attempts to contractually waive liability are declared void.
  • Transparency / reporting
    • Gender clinics must report statistics to the Department of Health and Human Services using a form developed by the Department.
    • Required data include dates of procedures/referrals, patient age and sex, and for drugs: drug name, dosage, frequency/duration, administration method (and other data items in the draft).

Who is affected

  • Minors and their parents/guardians (restrictions on transition care; parental consent for certain exceptions)
  • Medical professionals and licensing boards (new disciplinary grounds)
  • Health care entities and gender clinics (reporting obligations; potential civil fines)
  • Detransitioners (expanded access to civil remedies and potential coverage of detransition costs)

Procedural & timeline notes

  • Status in packet: passed 1st reading (April 14, 2025 listed in some entries); committee activity and amendments appear in the record (committee substitute and edits to civil‑action time limits and penalty language).
  • The bill text in the packet shows active amendment and truncation marks; some provisions (timelines, precise license sanctions) are subject to committee amendment.

Potential impacts

  • Increased legal liability and insurance exposure for providers and clinics offering gender‑affirming care to minors.
  • Administrative burden on clinics for required data reporting.
  • Broadened civil remedies for persons harmed by transition care, and explicit entitlement to recover costs of detransition procedures.
  • The bill’s exceptions, definitions, and time‑limit language vary across drafts — final impacts will depend on the enacted version.

If you want, I can produce a side‑by‑side of the key draft amendments (committee changes) or a short plain‑language explainer of how the bill would change clinical practice and liability for providers.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.